Correlating structure and function of drug-metabolizing enzymes: progress and ongoing challenges.

Area of Science:

• Pharmacology and Experimental Therapeutics
• Biophysics
• Drug Metabolism

Background:

• Cytochrome P450 (P450) enzymes are crucial for drug metabolism.
• Knowledge of P450 structures has advanced, but challenges remain in predicting ligand interactions due to active site flexibility.
• Understanding P450 interactions with membranes, other proteins like reductase and cytochrome b5, is limited.

Purpose of the Study:

• To summarize recent advances and challenges in P450 research presented at a symposium.
• To highlight the application of P450 structure-function knowledge in drug design and metabolism control.
• To discuss new biophysical approaches for studying P450 protein interactions.

Main Methods:

• Structural biology of human drug-metabolizing P450 enzymes.
• Investigation of P450 interactions with membranes and other proteins using reconstituted systems and cells.
• Application of protein nuclear magnetic resonance (NMR) to probe P450-cytochrome b5 and P450-reductase interactions.
• Development of selective P450 inhibitors.

Main Results:

• While P450 structures are known, active site flexibility impacts ligand prediction.
• P450 interactions with reductase and cytochrome b5 are complex and mutually exclusive, modulated by ligands.
• Protein NMR identified specific interaction surfaces and confirmed mutual exclusivity of b5 and reductase binding.
• A CYP3A4 inhibitor was developed to slow the clearance of HIV drugs.

Conclusions:

• Continued integration of biophysical approaches is essential for advancing P450 structure-function understanding.
• Translational advances in drug design and metabolism modulation are expected.
• Accurate prediction of P450-ligand interactions remains a significant challenge.